首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   175430篇
  免费   15699篇
  国内免费   11615篇
耳鼻咽喉   1496篇
儿科学   1951篇
妇产科学   2760篇
基础医学   19808篇
口腔科学   2793篇
临床医学   22685篇
内科学   27257篇
皮肤病学   1807篇
神经病学   9227篇
特种医学   6223篇
外国民族医学   91篇
外科学   18476篇
综合类   28980篇
现状与发展   30篇
一般理论   10篇
预防医学   11611篇
眼科学   5025篇
药学   18213篇
  174篇
中国医学   9520篇
肿瘤学   14607篇
  2024年   604篇
  2023年   2666篇
  2022年   6810篇
  2021年   8656篇
  2020年   6463篇
  2019年   5735篇
  2018年   5934篇
  2017年   5352篇
  2016年   5095篇
  2015年   7647篇
  2014年   9560篇
  2013年   9009篇
  2012年   13336篇
  2011年   14282篇
  2010年   9233篇
  2009年   7348篇
  2008年   9333篇
  2007年   9274篇
  2006年   9090篇
  2005年   8756篇
  2004年   5920篇
  2003年   5500篇
  2002年   4602篇
  2001年   4036篇
  2000年   4019篇
  1999年   4184篇
  1998年   2667篇
  1997年   2593篇
  1996年   1900篇
  1995年   1742篇
  1994年   1521篇
  1993年   968篇
  1992年   1386篇
  1991年   1215篇
  1990年   1070篇
  1989年   931篇
  1988年   814篇
  1987年   760篇
  1986年   585篇
  1985年   527篇
  1984年   295篇
  1983年   211篇
  1982年   135篇
  1981年   128篇
  1980年   89篇
  1979年   134篇
  1978年   75篇
  1976年   55篇
  1975年   63篇
  1974年   74篇
排序方式: 共有10000条查询结果,搜索用时 14 毫秒
1.
2.

Background

Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.

Objectives

To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.

Methods

Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.

Results

Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.

Conclusions

These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study.  相似文献   
3.
Abstract

Background

Comorbidities are commonly seen in patients with coronavirus disease 2019 (COVID-19), but the clinical implication is not yet well-delineated. We aim to characterize the prevalence and clinical implications of comorbidities in patients with COVID-19.  相似文献   
4.
5.
Signaling of RANK (receptor activator of nuclear factor kappa B) through its ligand RANKL appears critical in osteolysis associated with aseptic loosening (AL). The purpose of this study was to investigate the role of RANK in a murine osteolysis model developed in RANK knockout (RANK(-/-)) mice. Ultra high molecular weight polyethylene (UHMWPE) debris was introduced into established air pouches on RANK(-/-) mice, followed by implantation of calvaria bone from syngeneic littermates. Wild type C57BL/6 (RANK(+/+)) mice injected with either UHMWPE or saline alone were included in this study. Pouch tissues were collected 14 days after UHMWPE inoculation for molecular and histology analysis. Results showed that UHMWPE stimulation induced strong pouch tissue inflammation in RANK(-/-) mice, as manifested by inflammatory cellular infiltration, pouch tissue proliferation, and increased gene expression of IL-1beta, TNFalpha, and RANKL. However, the UHMWPE-induced inflammation in RANK(-/-) mice was not associated with the osteoclastic bone resorption observed in RANK(+/+) mice. In RANK(+/+) mice subjected to UHMWPE stimulation, a large number of TRAP(+) cells were found on the implanted bone surface, where active osteoclastic bone resorption was observed. No TRAP(+) cells were found in UHMWPE-containing pouch tissues of RANK(-/-) mice. Consistent with the lack of osteoclastic activity shown by TRAP staining, no significant UHMWPE particle-induced bone resorption was found in RANK(-/-) mice. A well preserved bone collagen content (Van Gieson staining) and normal plateau surface contour [microcomputed tomography (microCT)] of implanted bone was observed in RANK(-/-) mice subjected to UHMWPE stimulation. In conclusion, this study provides the evidence that UHMWPE particles induce strong inflammatory responses, but not associated with osteoclastic bone resorption in RANK(-/-) mice. This indicates that RANK signaling is essential for UHMWPE particle-induced osteoclastic bone resorption, but does not participate in UHMWPE particle-induced inflammatory response.  相似文献   
6.
晶体玻璃体视网膜联合手术治疗复杂性视网膜脱离   总被引:6,自引:2,他引:4  
目的探讨玻璃体视网膜手术(vitreretinalsurgery,VR术)联合晶体切除/超声粉碎的效果。方法对81例(81只眼)应用晶体玻璃体视网膜联合手术(lenticular-vitreoretinalsurgery,LVR术)治疗的复杂性视网膜脱离进行回顾性分析。结果解剖性成功者64只眼(79.01%),功能性成功者45只眼(55.56%);手术成功率显著降低的原因是前部增殖性玻璃体视网膜病变(proliferativevitreo-retinopathy,PVR)(成功率42.86%,P<0.01)和术中/术后眼内出血(成功率58.82%,P<0.025)。结论LVR术是治疗复杂性视网膜脱离的主要方法;显著影响手术预后的因素是前部PVR和术中/术后眼内出血。  相似文献   
7.
医源性胆管狭窄X线表现   总被引:1,自引:0,他引:1  
本文报道了13例医源性胆管狭窄,分析其影像表现。特点为:环形狭窄;线样狭窄,包括规则的和不规则的线样狭窄;闭塞性狭窄;胆管闭塞和胆管中断分离。ERCT和PCT对狭窄的形态,位置及长度显示优于CT和US。  相似文献   
8.
9.
The apoenzyme of glutamate decarboxylase [enzyme without bound cofactor, pyridoxal 5'-phosphate (pyridoxal-P)] serves as a reservoir of inactive glutamate decarboxylase (GAD) that can be activated when additional GABA synthesis is required. We have investigated which of two molecular forms of GAD is present as apoenzyme in synaptosomes and in cortex, caudate nucleus, hippocampus, and cerebellum of rat brain. Endogenous glutamate apodecarboxylase (apoGAD) was labeled by incubating extracts of synaptosomes or punches of each region with 32P-pyridoxal-P, followed by reduction with NaBH4, to link covalently the 32P-pyridoxal-P to GAD. Proteins were separated by SDS-PAGE. Punches from all four brain regions and forebrain synaptosomes contained two forms of GAD with apparent Mrs of 63 and 65 kDa as identified by immunoblotting with four antiGAD sera. Punches and synaptosomes contained a major 32P-pyridoxal-P-labeled band with an apparent Mr of 63 kDa that was stained on immunoblots by the antiGAD serum 1440 and the monoclonal antibody GAD-6, and a minor labeled band at 65 kDa that was stained by the 1440, 6799, and K2 antisera. Synaptosomes contained remarkably few other strongly labeled proteins, but punches contained several other labeled bands. Three additional lines of evidence indicate that the labeled 63-kDa protein is apoGAD: (1) it was purified by immunoaffinity chromatography with the GAD-1 monoclonal antibody; (2) it yielded one major labeled peptide when digested with chymotrypsin, and that peptide appeared identical in peptide-mapping experiments to the labeled active-site peptide isolated from chromatographically prepared rat brain GAD; and (3) its labeling was selectively blocked by 4-deoxypyridoxine 5'-phosphate, a competitive inhibitor of the binding of pyridoxal-P to GAD.(ABSTRACT TRUNCATED AT 250 WORDS)  相似文献   
10.
The efficacy of radiology in evaluating dysphagia was studied in 86 patients by comparison to endoscopic findings. In the 66 patients with endoscopic abnormalities radiology was correct in 54, for a sensitivity of 82%. Sensitivity of radiology improved to 95% if mild esophagitis was excluded. In the 20 patients with normal endoscopy, radiology was normal in 18 (90%). Thus radiology proved to be a reliable means of evaluating the esophagus in patients with dysphagia.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号